Traditional Chinese medicine composition for treating colorectal cancer and application of traditional Chinese medicine composition

Abstract

The invention relates to a traditional Chinese medicine composition for treating colorectal cancer and application of the traditional Chinese medicine composition. The traditional Chinese medicine composition is made of the following raw material medicines in parts by weight: 25-35 parts of unprocessed astragalus roots, 12-18 parts of flavescent sophora roots, 14-16 parts of pilose asiabell roots,15-20 parts of parched white atractylodes rhizome, 15-25 parts of white poria, 25-35 parts of fried coix seeds, 25-35 parts of hedyotis diffusa, 1-3 parts of geckos, 1-3 parts of centipedes and 3-9 parts of licorice roots. The traditional Chinese medicine composition provided by the invention is rigorous in component, reasonable in material selection, reasonable in compatibility and simple in medicine and specific in effect, and effects of tonifying qi and nourishing the spleen and removing stasis and dredging collaterals are taken into play synergistically. Animal tests and clinical experiments show that when being adopted to treat colorectal cancer, the composition is capable of remarkably inhibiting growth of tumors, increasing the survival rate, improving health situations of patientsand improving the living quality of the patients and is excellent in effect.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine compositions, in particular to a traditional Chinese medicine composition for treating colorectal cancer and its application. Background technique [0002] Colorectal cancer (CRC) is the most common malignant tumor of digestive tract. According to the 2018 global cancer statistics, colorectal cancer is the third most common cancer in the world and the second most deadly. The mortality rate of colorectal cancer in my country has shown a downward trend in the past 30 years, but the incidence rate has risen rapidly and the trend of rejuvenation is becoming more and more obvious. The onset of colorectal cancer is hidden, the early symptoms are not obvious, and most of them are in the middle and late stage when diagnosed. About 15% to 25% of the patients are accompanied by distant metastasis when they are diagnosed, and another 18% to 25% of the patients develop distant metastasis...

AI Technical Summary

Problems solved by technology

Due to the fact that digestive endoscopy has not been fully popularized in my country, and the early symptoms of colorectal cancer are not obvious, most patients are already in the advanced stage once they are discovered. agglomerated tumor mass

Images